Cell-free fetal DNA testing: Who is driving implementation?

Genetics in Medicine

Volumn 15, Issue 6, 2013, Pages 433-434

  Mozersky, Jessica ^a   Mennuti, Michael T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA FRAGMENT;

ANEUPLOIDY; CELL FREE FETAL DNA TESTING; CELL FREE SYSTEM; CLINICAL PRACTICE; DNA DETERMINATION; GENETIC COUNSELING; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; INFORMED CONSENT; MEDICAID; MOSAICISM; NOTE; OBSTETRIC PROCEDURE; PATIENT CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; REIMBURSEMENT; TWIN PREGNANCY;

CELL-FREE SYSTEM; DNA; GENETIC TESTING; HUMANS; PRENATAL DIAGNOSIS;

EID: 84878879865     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2012.156     Document Type: Note

References (5)

1. Hayden EC. Fetal tests spur legal battle. Nature 2012;486(7404):454.
2. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-920.
3. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
4. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206: 319.e1-319.e9.
5. Wilfond BS, Nolan K. National policy development for the clinical application of genetic diagnostic technologies. Lessons from cystic fibrosis. JAMA 1993;270:2948-2954. (Pubitemid 24000802)